Biolistic Particle Gun Market

Global Biolistic Particle Gun Market, Size, Share and Trends Analysis Report, By Size (Fixed and Portable), By Application (Hospitals and Clinics, Genetic Research Institutes, and Others), Forecast Period (2021-2027)

Published: Dec 2021 | Report Code: OMR2025214 | Category : Medical Devices | Delivery Format: /

The global biolistic particle gun market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). A biolistic particle gun is also known as a gene gun, which is the transportation process or technique that delivers exogenous DNA or foreign DNA (transgenes) into the cells. In animals and plants, the biolistic particle gun is capable to transform and manipulate the genetic makeup of the tissues, cells, and organelles by directly injecting the genetic information at a target site. 

The emergence of genetic engineering and recombinant DNA technology are two major factors that positively impact the growth of the global biolistic particle gun market during the forecast period. The rising incidence of transformation experiments by various researchers and scientists is anticipated to surge the demand for biolistic particle guns owing to their varied application in these experiments.  Thus, it is projected to create ample opportunities for biolistic particle guns and supplement the market growth of the global biolistic particle gun market during the forecast period. Additionally, the increasing trends toward research and development in the life science sector, inclination toward genetically modified crops, advancement in agriculture, and rapid technological advancement in biolistic particle gun technology are some dominant factors that are expected to drive the global biolistic particle gun market during the forecast period.

Besides, the key players present in the global biolistic particle gun market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and Wealtec Corp., among others, adopted various strategies that include product launches, mergers & acquisitions, among others to remain sustainable and competitive in the market. For instance, in October 2021, Bio-Rad Laboratories announced the launch of the biolistic PDS-100/He particle delivery system. The gun is designed with efficient features and employs helium that is released with high pressure by a rupture disk to hit the target cells and transform genetic makeup. 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape- Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and Wealtec Corp., among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Biolistic Particle Gun Market Report Segmentation

By Size

o Fixed

o Portable

By Application

o Hospitals and Clinics 

o Genetic Research Institutes

o Others

Global Biolistic Particle Gun Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World